amoxicillin achat www.antibioticsonlinerx.com
Chemicals Stocks

FMC Corp Valuation – March 2018 $FMC

Company Profile (obtained from Marketwatch): FMC Corp. engages in the provision of innovative solutions, applications, and products for the agricultural, industrial, and consumer markets. It operates through the following segments: FMC Agricultural Solutions, FMC Health and Nutrition, and FMC Lithium. The FMC Agricultural Solutions segment develops, markets, and sells all three major classes of crop protection chemicals: insecticides, herbicides and fungicides. The FMC Health and Nutrition segment focuses on nutritional ingredients, health excipients, and functional health ingredients. The Lithium segment manufactures lithium for use in lithium products, which are used primarily in energy storage, specialty polymers, and chemical synthesis application. The company was founded by John Bean in 1883 and is headquartered in Philadelphia, PA.

FMC Chart

FMC data by YCharts

 

Downloadable PDF version of this valuation:

ModernGraham Valuation of FMC – March 2018

Stage 1: Is this company suitable for the Defensive Investor or the Enterprising Investor?

What kind of Intelligent Investor are you?

Defensive Investor; must pass 6 out of the following 7 tests.
1. Adequate Size of the Enterprise Market Cap > $2Bil $11,043,028,691 Pass
2. Sufficiently Strong Financial Condition Current Ratio > 2 1.65 Fail
3. Earnings Stability Positive EPS for 10 years prior Pass
4. Dividend Record Dividend Payments for 10 years prior Pass
5. Earnings Growth Increase of 33% in EPS in past 10 years using 3 year averages at beginning and end 104.91% Pass
6. Moderate PEmg Ratio PEmg < 20 21.76 Fail
7. Moderate Price to Assets PB Ratio < 2.5 OR PB*PEmg < 50 4.12 Fail
Enterprising Investor; must pass 4 out of the following 5 tests, or be suitable for the Defensive Investor.
1. Sufficiently Strong Financial Condition Current Ratio > 1.5 1.65 Pass
2. Sufficiently Strong Financial Condition Debt to NCA < 1.1 2.07 Fail
3. Earnings Stability Positive EPS for 5 years prior Pass
4. Dividend Record Currently Pays Dividend Pass
5. Earnings Growth EPSmg greater than 5 years ago Pass

 

Stage 2: Determination of Intrinsic Value

EPSmg $3.78
MG Growth Estimate 9.05%
MG Value $100.52
Opinion Fairly Valued
MG Grade C+
MG Value based on 3% Growth $54.81
MG Value based on 0% Growth $32.13
Market Implied Growth Rate 6.63%
Current Price $82.25
% of Intrinsic Value 81.83%

FMC Corp is suitable for the Enterprising Investor but not the more conservative Defensive Investor. The Defensive Investor is concerned with the low current ratio, high PEmg and PB ratios. The Enterprising Investor is only concerned with the level of debt relative to the net current assets. As a result, all Enterprising Investors following the ModernGraham approach should feel comfortable proceeding with the analysis.

As for a valuation, the company appears to be Fairly Valued after growing its EPSmg (normalized earnings) from $2.36 in 2014 to an estimated $3.78 for 2018. This level of demonstrated earnings growth supports the market’s implied estimate of 6.63% annual earnings growth over the next 7-10 years. As a result, the ModernGraham valuation model, based on the Benjamin Graham value investing formula, returns an estimate of intrinsic value within a margin of safety relative to the price.

At the time of valuation, further research into FMC Corp revealed the company was trading above its Graham Number of $48.75. The company pays a dividend of $0.66 per share, for a yield of 0.8% Its PEmg (price over earnings per share – ModernGraham) was 21.76, which was below the industry average of 31.55, which by some methods of valuation makes it one of the most undervalued stocks in its industry. Finally, the company was trading above its Net Current Asset Value (NCAV) of $-21.36.

FMC Corp receives an average overall rating in the ModernGraham grading system, scoring a C+.

Stage 3: Information for Further Research

Net Current Asset Value (NCAV) -$21.36
Graham Number $48.75
PEmg 21.76
Current Ratio 1.65
PB Ratio 4.12
Current Dividend $0.66
Dividend Yield 0.80%
Number of Consecutive Years of Dividend Growth 0

Useful Links:

ModernGraham tagged articles Morningstar
Google Finance MSN Money
Yahoo Finance Seeking Alpha
GuruFocus SEC Filings

Most Recent Balance Sheet Figures

Balance Sheet Information 12/1/2017
Total Current Assets $3,652,700,000
Total Current Liabilities $2,209,400,000
Long-Term Debt $2,993,000,000
Total Assets $9,206,300,000
Intangible Assets $3,830,700,000
Total Liabilities $6,524,500,000
Shares Outstanding (Diluted Average) 134,468,000

Earnings Per Share History

EPS History
Next Fiscal Year Estimate $5.29
Dec2017 $3.99
Dec2016 $1.56
Dec2015 $3.66
Dec2014 $2.29
Dec2013 $2.16
Dec2012 $3.00
Dec2011 $2.55
Dec2010 $1.18
Dec2009 $1.56
Dec2008 $2.01
Dec2007 $0.86
Dec2006 $0.83
Dec2005 $0.73
Dec2004 $1.07
Dec2003 $0.19
Dec2002 $0.48
Dec2001 -$2.72
Dec2000 $0.88
Dec1999 $1.64
Dec1998 $0.76

Earnings Per Share – ModernGraham History

EPSmg History
Next Fiscal Year Estimate $3.78
Dec2017 $2.93
Dec2016 $2.44
Dec2015 $2.83
Dec2014 $2.36
Dec2013 $2.29
Dec2012 $2.26
Dec2011 $1.80
Dec2010 $1.38
Dec2009 $1.39
Dec2008 $1.23
Dec2007 $0.81
Dec2006 $0.74
Dec2005 $0.45
Dec2004 $0.20
Dec2003 -$0.13
Dec2002 -$0.12

Recommended Reading:

Other ModernGraham posts about the company

10 Most Undervalued Companies for the Defensive Investor – May 2016
10 Most Undervalued Companies for the Defensive Investor – February 2016
10 Low PE Stocks for the Defensive Investor – February 2016
18 Best Stocks For Value Investors This Week – 1/30/16
FMC Corporation Valuation – January 2016 Update $FMC

Other ModernGraham posts about related companies

Koppers Holdings Inc Valuation – March 2018 $KOP
Kraton Corp Valuation – March 2018 $KRA
Quaker Chemical Corp Valuation – March 2018 $KWR
Sensient Technologies Corp Valuation – March 2018 $SXT
Albemarle Corp Valuation – March 2018 $ALB
Praxair Inc Valuation – March 2018 $PX
Ingevity Corp Valuation – March 2018 $NGVT
PolyOne Corp Valuation – March 2018 $POL
Green Plains Inc Valuation – March 2018 $GPRE
Eastman Chemical Co Valuation – March 2018 $EMN

Disclaimer:

The author did not hold a position in any company mentioned in this article at the time of publication and had no intention of changing that position within the next 72 hours.  See my current holdings here.  This article is not investment advice; any reader should speak to a registered investment adviser prior to making any investment decisions.  ModernGraham is not affiliated with the company in any manner.  Please be sure to review our detailed disclaimer.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Back To Top